選項

處方審核助手

{:__('collect %s',處方審核助手)}

輔助藥師快速識別處方中的潛在藥物相互作用、劑量異常及禁忌症,提升用藥安全。

提示內容 複製 複製

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male with a history of hypertension and mild renal insufficiency, currently prescribed amoxicillin, ibuprofen, and warfarin. Focus on analyzing the bleeding risk associated with combining ibuprofen and warfarin, evaluate the necessity of dose adjustment for amoxicillin in the context of renal insufficiency, and identify any other potential drug interactions or contraindications. Finally, provide clear medication recommendations or adjustment plans.

複製 複製

請作為資深臨床藥師,對以下患者處方進行合規性審查:患者為65歲男性,既往有高血壓和輕度腎功能不全病史,當前開具了阿莫西林、布洛芬及華法林。請重點分析布洛芬與華法林聯用對出血風險的影響,評估阿莫西林在腎功能不全情況下的劑量調整必要性,並指出是否存在其他潛在的藥物相互作用或禁忌症,最後給出明確的用藥建議或調整方案。

複製 複製
評論 (0)
0/300

推薦

處方審核助手
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract the drug name, dosage, route of administration, and frequency from the prescription, and cross-reference them with the patient's diagnosis, allergy history, and liver/kidney function indicators. Focus on identifying incompatibilities, overdosage, or violations of administration time windows. If potential risks are found, provide specific adjustment suggestions or alternative plans based on the latest clinical medication guidelines, along with the rationale. Finally, generate a structured audit summary listing all potential risk points and corresponding handling suggestions to ensure medication safety and adherence to medical standards.
術後復健助手
Act as a senior nursing assistant in the hospital's rehabilitation department. Based on the patient's vital signs, wound healing grade, and pain score on post-operative day 3, generate a detailed recovery progress assessment report. The report must include an objective analysis of the current recovery status, identify potential risk factors such as signs of infection or restricted mobility, and propose specific next-step care suggestions, including physical therapy frequency, dietary adjustments, and home care precautions, ensuring the content is professional and easy for patients to understand.
處方審核助手
Act as a senior clinical pharmacist to conduct a comprehensive compliance review of the provided patient prescription. First, analyze the patient's medical history, allergy records, and current medications to identify potential drug interactions or contraindications. Second, verify that the dosage, route of administration, and frequency align with standard treatment guidelines and the patient's individual characteristics, such as renal or hepatic function. Finally, if any potential risks or irregularities are found, clearly specify the issues and provide evidence-based correction suggestions or warnings to ensure the prescription is safe and effective.
處方審核助手
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male with a history of hypertension, type 2 diabetes, and mild renal impairment. The current prescription includes Amoxicillin, Metformin, Amlodipine, and Ibuprofen. Focus on analyzing potential drug-drug interactions, specifically the impact of NSAIDs on renal function and blood pressure, as well as potential interactions between antibiotics and hypoglycemic agents, and provide adjustment suggestions or warnings.
處方審核助手
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether dosages align with the patient's age, weight, and hepatic/renal function. If risks are identified, clearly specify the drug combination and risk level, and provide adjustment suggestions or alternative regimens based on the latest clinical guidelines to ensure medication safety and efficacy.
處方審核助手
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, and identify potential risks based on the latest clinical guidelines, finally providing a clear audit conclusion and adjustment suggestions.
OR